AU2002210491A1 - Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof - Google Patents

Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof

Info

Publication number
AU2002210491A1
AU2002210491A1 AU2002210491A AU1049102A AU2002210491A1 AU 2002210491 A1 AU2002210491 A1 AU 2002210491A1 AU 2002210491 A AU2002210491 A AU 2002210491A AU 1049102 A AU1049102 A AU 1049102A AU 2002210491 A1 AU2002210491 A1 AU 2002210491A1
Authority
AU
Australia
Prior art keywords
longlasting
agent
produce
retention time
time used
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002210491A
Other languages
English (en)
Inventor
Gunther Beisel
Rudiger Groning
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU2002210491A1 publication Critical patent/AU2002210491A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/29—Mineral substances, e.g. mineral oils or clays
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/24—Cellulose or derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dispersion Chemistry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2002210491A 2000-09-11 2001-09-07 Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof Abandoned AU2002210491A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10044846 2000-09-11
DE10044846A DE10044846A1 (de) 2000-09-11 2000-09-11 Mittel mit verlängerter Magenverweilzeit zur Erzeugung eines langanhaltenden Sättigungseffektes sowie dessen Verwendung
PCT/EP2001/010309 WO2002019842A2 (de) 2000-09-11 2001-09-07 Mittel mit verlängerter magenverweilzeit zur erzeugung eines langanhaltenden sättigungseffektes sowie dessen verwendung

Publications (1)

Publication Number Publication Date
AU2002210491A1 true AU2002210491A1 (en) 2002-03-22

Family

ID=7655784

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002210491A Abandoned AU2002210491A1 (en) 2000-09-11 2001-09-07 Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof

Country Status (7)

Country Link
US (1) US20030161885A1 (enExample)
EP (1) EP1322182A2 (enExample)
JP (1) JP2004508310A (enExample)
AU (1) AU2002210491A1 (enExample)
CA (1) CA2419389A1 (enExample)
DE (1) DE10044846A1 (enExample)
WO (1) WO2002019842A2 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10247910A1 (de) * 2002-10-14 2004-04-22 Beisel, Günther Mittel zur Erzeugung eines langanhaltenden Sättigungseffektes
EP1572238A1 (de) * 2002-12-19 2005-09-14 Günther Beisel Mittel mit retardierter stofffreisetzung
WO2004056199A1 (de) * 2002-12-19 2004-07-08 Beisel Guenther Zubereitung zur appetitminderung, sättigung und/oder gewichtsreduktion für kinder
EP3188713B2 (en) * 2014-08-11 2024-04-10 perora GmbH Method of inducing satiety
LT3188717T (lt) * 2014-08-11 2020-03-25 Perora Gmbh Vaisto forma, apimanti daleles
CA2989510A1 (en) 2015-07-07 2017-01-12 Perora Gmbh Method of inducing satiety
AU2017220691A1 (en) 2016-02-18 2018-08-09 Perora Gmbh Kits comprising satiety-inducing formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5756450A (en) * 1987-09-15 1998-05-26 Novartis Corporation Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
US5855917A (en) * 1996-12-04 1999-01-05 Wisconsin Alumni Research Foundation Method for controlling body fat and/or body weight in animals and pharmaceutical compositions for use therein comprising 20-carbon conjugated unsaturated fatty acids
US6054480A (en) * 1997-09-18 2000-04-25 Nectra, Inc. Fatty acids as a diet supplement

Also Published As

Publication number Publication date
WO2002019842A3 (de) 2007-11-15
JP2004508310A (ja) 2004-03-18
CA2419389A1 (en) 2003-02-20
US20030161885A1 (en) 2003-08-28
WO2002019842A2 (de) 2002-03-14
DE10044846A1 (de) 2002-04-04
EP1322182A2 (de) 2003-07-02

Similar Documents

Publication Publication Date Title
AU2001256184A1 (en) 6-aminoalkyl-dihydropyrimidines and the use thereof as medicaments against viraldiseases
MXPA03005923A (es) Derivados de glupopiranosiloxipirazol y su uso en medicinas.
EP1347980A4 (en) RECEPTOR SPECIFIC COMPOUNDS OF ADENOSINE-A1, -A2A, AND-A3 AND USES THEREOF
HUP0301243A3 (en) Herbicidal substituted pyridine-ketones, preparation and use thereof
MXPA03005731A (es) Articulo absorbente que tiene tratamientos medicinales liberables.
MXPA02010914A (es) Amidas de antranilo y su uso como medicamentos.
MXPA03004932A (es) 2-anilino-bencimidazoles sustituidos y su uso como inhibidores de nhe.
AU8420301A (en) Use
AU2001240637A1 (en) Novel imidazotriazinones and the use thereof
HUP0303291A3 (en) Herbicidal composition, preparation and use thereof
AU2001275677A1 (en) 3,4-dihydroxybenzyl-substituted carbonic acid derivatives and the use thereof as antioxidants
HUP0303369A3 (en) Herbicidal composition, preparation and use thereof
GB0026467D0 (en) Compound, composition and use
AU2001235363A1 (en) Mibefradil analogues and their use
AU2002210491A1 (en) Agent having prolonged stomach retention time used to produce a longlasting saturation effect, and the use thereof
IL154675A0 (en) N-(3,5-dichloro-2-methoxyphenyl)-4-methoxy-3-piperazin-1-yl-benzenesulfonamide
HUP0300222A3 (en) Novel lhrh-antagonists, production and use thereof as medicament
AU5464901A (en) Dichloropyridyl- and dichloroisothiazolyl-thiocarboxamides and their use as microbicides
AU2000231564A1 (en) Phosphororganic compounds and the use thereof
AU3956502A (en) Saframycins, analogues and uses thereof
GB0005301D0 (en) Compound, composition and use
DE50107204D1 (de) 8beta-substituierte-11beta-pentyl-und 11beta-hexyl-estra-1,3,5(10)-trienderivate
AU7815201A (en) Synthetic salicylihalamides, apicularens and derivatives thereof
GB0000131D0 (en) Thiolactomycin analogues,compositions containing the same and uses thereof
AU2001252046A1 (en) New bacteriocin, production and use thereof